Expression of PD-1 by TILs and expression of its ligand (PD-L1) by tumor and myeloid cells (15–17) is also a favorable prognostic feature in HGSC, likely reflecting the role of this pathway in active antitumor immunity (18). This evidence concerns the gene CD274 and neoplasm.